Skip to main content
# Title Department Research Year
81 Design, synthesis, crystal structures and biological evaluation of some 1, 3-thiazolidin-4-ones as dual CDK2/EGFR potent inhibitors with potential apoptotic antiproliferative effects 2022
82 Combinatorial Therapy of Letrozole- and Quercetin-Loaded Spanlastics for Enhanced Cytotoxicity against MCF-7 Breast Cancer Cells Department of Pharmaceutics 2022
83 Design and synthesis of new triarylimidazole derivatives as dual inhibitors of BRAFV600E/p38α with potential antiproliferative activity Department of Pharmaceutical Organic Chemistry 2022
84 Selective Cytotoxic Constituents from Gardenia latifolia and Their In Silico Topoisomerase IIα Inhibition Department of Pharmacognosy 2022
85 Design and optimization of PEGylated silver nanoparticles for efficient delivery of Doxorubicin to cancer cells Department of Industrial Pharmacy 2022
86 Dual Targeting of Steroid Sulfatase and 17β-Hydroxysteroid Dehydrogenase Type 1 by a Novel Drug-Prodrug Approach: A Potential Therapeutic Option for the Treatment of Endometriosis Department of Pharmaceutical Organic Chemistry 2022
87 Synthesis, computational study and biological evaluation of 9-acridinyl and 1-coumarinyl-1, 2, 3-triazole-4-yl derivatives as topoisomerase II inhibitors Department of Medicinal Chemistry 2022
88 Antibacterial and wound-healing potential of PLGA/spidroin nanoparticles: a study on earthworms as a human skin model 2022
89 Synthesis and Biological Evaluation of Indole-2-Carboxamides with Potent Apoptotic Antiproliferative Activity as EGFR/CDK2 Dual Inhibitors 2022
90 New 1,2,3-triazole linked ciprofloxacin-chalcones induce DNA damage by inhibiting human topoisomerase I& II and tubulin polymerization Department of Pharmaceutical Organic Chemistry 2022